Allergic rhinoconjunctivitisH10.1

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Common occurrence of rhinitis allergica and conjunctivitis due to type 1 allergy mostly to pollen ( pollinosis) of grasses, cereals, trees, shrubs and herbs.

General therapyThis section has been translated automatically.

Avoidance of triggering allergens, see Table 1. Complete allergen elimination is rarely possible with aerogenically transmitted allergens, but allergen reduction is often sufficient.

Notice! In addition to alleviating symptoms, the treatment focuses on preventing the change of levels

from allergic rhinitis to bronchial asthma! In case of development of allergic asthma, treatment by the internist.

External therapyThis section has been translated automatically.

Instill Nedocromil (e.g. Irtan eye drops) 1 drop twice a day into both conjunctival sacs.

Internal therapyThis section has been translated automatically.

  • Antihistamines: If local therapy is not sufficient, in acute attacks or prophylactically during the time of pollen flight, additional antihistamines such as desloratadine (e.g. Aerius) 1-2 tbl/day, levocetirizine (e.g. Xusal) 1-2 tbl/day or cetirizine (Zyrtec) 1 tbl/day p.o.
  • Glucocorticoids: Only in exceptional cases the pre-seasonal glucocorticoid depot injection in combination with methylprednisolone (e.g.) 80-120 mg is to be used.
  • Immunotherapy, specific: Besides the absolute absence of allergens, this is the only therapy approach that can significantly reduce the probability of bronchial asthma. The indication for specific immunotherapy is given in cases of pronounced clinical symptoms (prick test and high RAST class are only indicative, not decisive criteria). Indications may be: increase in respiratory problems from year to year, positive family history of obstructive respiratory diseases, incipient obstructive respiratory complaints during the last pollen count, low age. The indication is also given in the case of inadequate therapeutic effects due to measures of allergen elimination or symptomatic drug therapies as well as high allergen exposure (especially occupational).
  • Notice! Deterioration or provocation of atopic eczema by specific immunotherapy of allergic rhinitis is possible!

  • Extracts are available for house dust mites, pollen and animal epithelia (cat, horse). The efficacy varies for the different allergens: Good chances of success exist with specific immunotherapy against house dust mites (reduction of symptoms in about 90% of cases), moderate chances of success with pollen and doubtful chances of success with specific immunotherapy against animal epithelia.
    Cave! Specific immunotherapy for patients with unspecific bronchial hyperreactivity!
    In patients with unspecific bronchial hyperreactivity, immunotherapy is associated with the risk of severe asthmatic exacerbations. In these cases, the retention of inhaled glucocorticoid therapy is often the most sensible solution for the patient.
    Selection of the allergen: Provocation testing (nasal/conjuctival) is generally recommended for the selection of the allergen and, in the case of specific immunotherapy against several plant groups, is indispensable for the identification of the allergen causing symptoms. More than 4 allergens of one plant group should not be added simultaneously to the hyposensitizing solution. As a rule, specific immunotherapy against a few allergens with the main responsibility also reduces the symptoms of other allergens, as these are also treated by cross-allergenicity.

TablesThis section has been translated automatically.

Allergenicity and effectiveness in allergic rhinitis

Allergen

allergenicity

Effectiveness

Pollen

Sleeping with windows closed

+

Washing your hair before going to bed

Do not leave clothes in the bedroom

Pollen filter, pollen warning

No physical exertion outdoors during the pollen flight

Fungal spores

Regular ventilation, especially during the winter months

++

Air circulation even in hidden corners of the apartment

Thermal insulation on the outer wall

House dust mites

Encasing

++

Reduction of dust traps

Reduction of the air humidity

Fine filter in vacuum cleaner

Acaricides

Animal Epithelia

Abolition of animals, especially for cat hair allergy

+

Regular washing of the animal if maintained

Thorough cleaning, especially of the upholstery

Other (coffee/rhizinus beans, latex, metal salts, flour, proteins, etc.)

Attempt to avoid allergens or reduce the concentration of allergens, especially in the workplace

(+)

Internal implementation

If necessary, change of profession after dermatological procedures

Note(s)This section has been translated automatically.

Oral and intramuscular applications of glucocorticosteroids should be avoided in children for the treatment of rhinitis.

LiteratureThis section has been translated automatically.

  1. Sennekamp J et al (2002) German Society for Allergology and Clinical Immunology (DGAI) and Medical Association of German Allergologists (ÄDA). AWMF Guidelines Register No. 061/013
  2. Bachert et al (2003) Guidelines of the German Society for Allergology and Clinical Immunology (DGAI) in coordination with the German Dermatological Society (DDG). AWMF Guidelines Register No. 061/014

Authors

Last updated on: 29.10.2020